Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Infinity: Interrogating biology

Infinity Pharmaceuticals Inc. is going about drug discovery by taking a road between the path of classical natural products chemistry and shotgun combinatorial chemistry.

Infinity's technology has its origins at Harvard University, where Stuart Schreiber and Mike Foley were developing the use of high throughput chemistry to interrogate biology. Their approach to chemistry was the converse of the retro-synthetic method used by chemists over the

Read the full 643 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers